1. Adenowo, A.F., et al., Impact of human schistosomiasis in sub-Saharan Africa. Brazilian Journal of Infectious Diseases, 2015. 19(2): p. 196-205.
2. Hotez, P.J., O.A. Asojo, and A.M. Adesina, Nigeria: "Ground Zero" for the High Prevalence Neglected Tropical Diseases. 2012, Public Library of Science.
3. WHO, Schistosomiasis: Progress report 2001–2011 and Strategic plan 2012–2020. 2013: p. 74.
4. Opio, C.K., et al., Profiling lifetime episodes of upper gastrointestinal bleeding among patients from rural Sub-Saharan Africa where Schistosoma mansoni is endemic. Pan Afr Med J, 2016. 24: p. 296.
5. Gray, D.J., et al., Diagnosis and management of schistosomiasis. BMJ, 2011. 342: p. d2651.
6. Kaatano, G.M., et al., Schistosoma mansoni-related hepatosplenic morbidity in adult population on Kome Island, Sengerema district, Tanzania. The Korean journal of parasitology, 2015. 53(5): p. 545.
7. Mueller, A., et al., Intestinal schistosomiasis of Ijinga Island, north-western Tanzania: prevalence, intensity of infection, hepatosplenic morbidities, and their associated factors. BMC infectious diseases, 2019. 19(1): p. 832.
8. Agha, A., et al., Use of the platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices in patients with schistosomiasis. Saudi J Gastroenterol, 2011. 17(5): p. 307-11.
9. Bessa, S. and I. Helmy, Injection sclerotherapy for esophageal varices caused by schistosomal hepatic fibrosis. Surgery, 1985. 97(2): p. 164-168.
10. El-Zayadi, A., S.S. El-Din, and S. Kabil, Endoscopic sclerotherapy versus medical treatment for bleeding esophageal varices in patients with schistosomal liver disease. Gastrointestinal Endoscopy, 1988. 34(4): p. 314-317.
11. LaBrecque, D., et al., Esophageal varices. World Gastroenterol Organ Glob Guidel, 2014. 2014: p. 1-14.
12. Hassan, M.A., et al., Noninvasive Prediction of Esophageal Varices Grade (Size) in Sudanese Patients with Periportal Fibrosis. Gastroenterology, 2018. 2(2): p. 28-33.
13. Agha, A., et al., Use of the platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices in patients with schistosomiasis. Saudi journal of gastroenterology: official journal of the Saudi Gastroenterology Association, 2011. 17(5): p. 307.
14. Richter, J., et al., Sonographic prediction of variceal bleeding in patients with liver fibrosis due to Schistosoma mansoni. Tropical Medicine & International Health, 1998. 3(9): p. 728-735.
15. Abdel-Wahab, M.F., et al., Ultrasonographic prediction of esophageal varices in Schistosomiasis mansoni. American Journal of Gastroenterology, 1993. 88(4).
16. Derbala, M., et al., Aspartate transaminase to platelet ratio index in hepatitis C virus and Schistosomiasis coinfection. World journal of gastroenterology, 2015. 21(46): p. 13132.
17. Barreto, A.V.M.S., et al., New index for the diagnosis of liver fibrosis in Schistosomiasis mansoni. Arquivos de gastroenterologia, 2017. 54(1): p. 51-56.
18. Chen, R., et al., Platelet count to spleen diameter ratio for the diagnosis of gastroesophageal varices in liver cirrhosis: a systematic review and meta-analysis. Gastroenterology research and practice, 2017. 2017.
19. Mudawi, H., Y. Ali, and M. El Tahir, Prevalence of gastric varices and portal hypertensive gastropathy in patients with Symmers periportal fibrosis. Ann Saudi Med, 2008. 28(1): p. 42-4.
20. Richter, J., et al., Ultrasound in schistosomiasis: a practical guide to the standard use of ultrasonography for assessment of schistosomiasis-related morbidity: Second international workshop, October 22-26 1996, Niamey, Niger. 2000, Geneva: World Health Organization.
21. Chou, R. and N. Wasson, Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review. Annals of internal medicine, 2013. 158(11): p. 807-820.
22. Giannini, E., et al., Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut, 2003. 52(8): p. 1200-1205.
23. Madwar, M.A., et al., A prospective study: prediction of the first variceal hemorrhage in schistosomal and non-schistosomal liver disease. J Egypt Public Health Assoc, 1997. 72(3-4): p. 395-409.
24. Chofle, A.A., et al., Oesophageal varices, schistosomiasis, and mortality among patients admitted with haematemesis in Mwanza, Tanzania: a prospective cohort study. BMC Infect Dis, 2014. 14: p. 303.
25. Xu, X.-D., et al., Ratio of platelet count/spleen diameter predicted the presence of esophageal varices in patients with schistosomiasis liver cirrhosis. European journal of gastroenterology & hepatology, 2016. 28(5): p. 588-591.
26. Fagerland, M.W., and D.W. Hosmer, A generalized Hosmer–Lemeshow goodness-of-fit test for multinomial logistic regression models. The Stata Journal, 2012. 12(3): p. 447-453.
27. Hanley, J.A. and B.J. McNeil, The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 1982. 143(1): p. 29-36.
28. Ravera, M., et al., Clinical and endoscopic aspects of hepatosplenic schistosomiasis in Uganda. Eur J Gastroenterol Hepatol, 1996. 8(7): p. 693-7.
29. Kheir, M.M., et al., Effects of single-dose praziquantel on morbidity and mortality resulting from intestinal schistosomiasis. East Mediterr Health J, 2000. 6(5-6): p. 926-31.
30. Saad, A.M., et al., Oesophageal varices in a region of Sudan endemic for Schistosoma mansoni. Br J Surg, 1991. 78(10): p. 1252-3.
31. Chofle, A.A., et al., Oesophageal varices, schistosomiasis, and mortality among patients admitted with haematemesis in Mwanza, Tanzania: a prospective cohort study. BMC infectious diseases, 2014. 14(1): p. 303.
32. Mudawi, H., and K. Ibrahim, Endoscopic variceal sclerotherapy in patients with Symmers periportal fibroses. Tropical doctor, 2007. 37(3): p. 179-181.
33. Hassan, M.A., et al., Noninvasive Prediction of Esophageal Varices Grade (Size) in Sudanese Patients with Periportal Fibrosis. International Journal of Gastroenterology, 2018. 2(2): p. 28.
34. Lambertucci, J.R., L.C. dos Santos Silva, and C.M. Antunes, Aspartate aminotransferase to platelet ratio index and blood platelet count are good markers for fibrosis evaluation in schistosomiasis mansoni. Revista da Sociedade Brasileira de Medicina Tropical, 2007. 40(5).
35. Leite, L.A.C., et al., Hemostatic dysfunction is increased in patients with hepatosplenic schistosomiasis mansoni and advanced periportal fibrosis. PLoS neglected tropical diseases, 2013. 7(7): p. e2314.
36. Leite, L.A.C., et al., Relationship between splenomegaly and hematologic findings in patients with hepatosplenic schistosomiasis. Revista brasileira de hematologia e hemoterapia, 2013. 35(5): p. 332-336.
37. Medeiros, T.B., et al., Correlation between platelet count and both liver fibrosis and spleen diameter in patients with schistosomiasis mansoni. Arquivos de gastroenterologia, 2014. 51(1): p. 34-38.
38. Zambam de Mattos, Â., et al., Aspartate aminotransferase-to-platelet ratio index (APRI) for the non-invasive prediction of esophageal varices. Annals of hepatology, 2013. 12(5): p. 810-814.
39. Zhang, F., et al., Predictive value of a noninvasive serological hepatic fibrosis scoring system in cirrhosis combined with oesophageal varices. Canadian Journal of Gastroenterology and Hepatology, 2018. 2018.